Bio-IT World | The All of Us research program is truly a collaboration of partners, each taking on responsibility for part of the project. Vibrent Health won the Participant Technology Systems Center award, versioning its Learning Health System to guide over one million participants through the process of recruitment, enrollment, engagement, and return of health information.

Bio-IT World News Brief | Bionano Genomics today announced the pricing of its initial public offering of 3,360,000 units at a public offering price of $6.125 per unit for aggregate gross proceeds of $20,580,000, before deducting the underwriting discounts and commissions and offering expenses.

Bio-IT World News Brief | The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding.

Bio-IT World Contributed Commentary | The biopharmaceutical industry is facing fast growing data movement challenges. The optimization of the data movement setup must be done in a holistic manner, not by each stack separately.

Bio-IT World | In April of this year St. Jude Children’s Research Hospital launched the St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world's largest public repository of pediatric cancer genomics data. What started with St. Jude’s isolated bioinformatics frustrations has expanded to a vision for global collaboration in pediatric oncology.

Bio-IT World | The process of creating the St. Jude Cloud was a difficult one for St. Jude Children’s Research Hospital. But St. Jude’s CIO and chair of Computational Biology believe the relationships cultivated during the process will create a user community as much within St. Jude as without.

Bio-IT World News Brief | OmniTier announced that in a joint study with researchers at the Mayo Clinic’s Center for Individualized Medicine, the company successfully demonstrated human DNA variant calling using de novo global assembly techniques with breakthrough performance and cost.